Alphabet reported solid fourth-quarter earnings, with the firm’s sales and operating margins growing 12% and 460 basis points ...

Amazon is using math to help solve one of artificial intelligence’s most intractable problems: its tendency to make up answers, and to repeat them back to us with confidence.

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

BofA analyst Tazeen Ahmad raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $540 from $522 and keeps a Buy rating on the ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

Get prepared with the key expectations. Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped ...

In India, many kids who work in retail markets have good math skills. They can quickly perform a range of calculations to complete transactions. But as a new study shows, these kids often perform ...

Google has launched Gemini 2.0, its most powerful AI model suite, as part of its expanding push into agentic artificial ...